CAAS Capital Management’s Sight Sciences SGHT Stock Holding History

CAAS Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-85,000	Closed	-$1.93M	–	1024
2021 Q3	$1.93M	Buy	+85,000	New	+$2.79M	0.04%	363

Other funds holding SGHT

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAAS Capital Management's SGHT Position: Q4 2021 in Review

CAAS Capital Management sold out of Sight Sciences (SGHT) in Q4 2021, closing a stake of 85,000 shares — an estimated $1.93M sold.

CAAS Capital Management first reported a position in SGHT in Q3 2021 and held it in 1 quarter. The position peaked at $1.93M in Q3 2021. 60 funds tracked by Wall St. Rank hold SGHT as of Q4 2021.

CAAS Capital Management reported no remaining Sight Sciences position as of Q4 2021 after selling out during the quarter.
CAAS Capital Management sold 85,000 Sight Sciences shares in Q4 2021, an estimated $1.93M.
CAAS Capital Management first reported a position in Sight Sciences in Q3 2021 and held it in 1 quarter.
CAAS Capital Management's Sight Sciences position peaked at $1.93M in Q3 2021.
60 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.